← Portfolio Scout

Portfolio company

Vigil Neuroscience

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

3 investors

Sectors

Digital Health

About

Vigil Neuroscience develops microglia-targeted medicines to treat neurodegenerative diseases for patients with rare and common brain disorders.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies